Long-term outcomes of hepatitis B virus-related cirrhosis treated with nucleos(t)ide analogs
Open Access
- 1 July 2017
- journal article
- Published by Elsevier BV in Journal of the Formosan Medical Association
- Vol. 116 (7), 512-521
- https://doi.org/10.1016/j.jfma.2016.08.006
Abstract
No abstract availableKeywords
Funding Information
- Chang Gung Memorial Hospital, Taiwan (CMRPG8C0961)
This publication has 41 references indexed in Scilit:
- Long‐term outcome of hepatitis B virus‐related Chronic Hepatitis under protracted nucleos(t)ide analoguesJournal of Viral Hepatitis, 2013
- Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapyHepatology, 2013
- Hepatocellular CarcinomaThe New England Journal of Medicine, 2011
- Hepatitis B virus DNA levels and outcomes in chronic hepatitis BHepatology, 2009
- Hepatitis B virus infectionThe Lancet, 2009
- Meta‐analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinomaAlimentary Pharmacology & Therapeutics, 2008
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateHepatology International, 2008
- Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA LevelJAMA, 2006
- Epidemiology and Natural History of Hepatitis BSeminars in Liver Disease, 2005
- Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver DiseaseThe New England Journal of Medicine, 2004